{
    "organizations": [],
    "uuid": "ca7ba80386e8158bac320d79bd3a2fb898b9ec49",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-guangdong-hybribio-biotech-unit-re/brief-guangdong-hybribio-biotech-unit-receives-permission-of-clinical-trial-granted-by-china-fda-idUSL3N1RA5C1",
    "ord_in_thread": 0,
    "title": "BRIEF-Guangdong Hybribio Biotech ‚Äçunit receives permission of clinical trial granted by China FDA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 28 (Reuters) - Guangdong Hybribio Biotech Co Ltd :\n* Says its wholly owned unit received permission of clinical trial granted by China FDA with respect to Chloroquine Phosphate Gel\nSource text in Chinese: goo.gl/F9hnLQ\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-03-28T21:50:00.000+03:00",
    "crawled": "2018-03-29T15:36:25.014+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "guangdong",
        "hybribio",
        "biotech",
        "co",
        "ltd",
        "say",
        "wholly",
        "owned",
        "unit",
        "received",
        "permission",
        "clinical",
        "trial",
        "granted",
        "china",
        "fda",
        "respect",
        "chloroquine",
        "phosphate",
        "gel",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}